- Home
- ACEL vs REPL Comparison
ACEL vs REPL Comparison
Compare ACEL & REPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ACEL | REPL |
|---|---|---|
| Founded | 2009 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.4M | 721.7M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ACEL | REPL |
|---|---|---|
| Price | $10.38 | $10.59 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $14.50 | $12.00 |
| AVG Volume (30 Days) | 345.1K | ★ 2.0M |
| Earning Date | 11-04-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.50 | N/A |
| Revenue | ★ $1,307,029,000.00 | N/A |
| Revenue This Year | $9.83 | N/A |
| Revenue Next Year | $4.14 | N/A |
| P/E Ratio | $20.92 | ★ N/A |
| Revenue Growth | ★ 7.97 | N/A |
| 52 Week Low | $9.02 | $2.68 |
| 52 Week High | $13.28 | $14.80 |
Technical Indicators
Market Signals| Indicator | ACEL | REPL |
|---|---|---|
| Relative Strength Index (RSI) | 54.36 | 71.76 |
| Support Level | $10.37 | $9.35 |
| Resistance Level | $10.72 | $11.26 |
| Average True Range (ATR) | 0.28 | 0.62 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 72.22 | 75.54 |
Price Performance
Historical ComparisonAbout ACEL Accel Entertainment Inc.
Accel Entertainment Inc is a distributed gaming and local entertainment operator in the United States. It is engaged in the installation, maintenance, operation, and servicing of gaming terminals and related equipment, redemption devices that disburse winnings and contain automated teller machine (ATM) functionality, and amusement devices in authorized non-casino locations such as restaurants, bars, taverns, convenience stores, liquor stores, truck stops, and grocery stores. The Company also operates stand-alone ATMs in gaming and non-gaming locations. It generates revenue from Net gaming, Amusement, Manufacturing, ATM fees, and others.
About REPL Replimune Group Inc.
Replimune Group Inc is a clinical-stage biotechnology company. It uses a proprietary RPx platform to design and develop product candidates that are intended to maximally activate the immune system against solid tumors. The RPx platform is based on a proprietary, engineered strain of herpes simplex virus 1, or HSV-1, backbone with payloads added to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The company focuses on developing oncolytic immunotherapies for the treatment of cancer. Its pipeline products include RP1, RP2, and RP3. The company operates in USA and UK, majority of revenue from USA.